Loading...
PHX logo

Pharmx Technologies LimitedASX:PHX Stock Report

Market Cap AU$56.6m
Share Price
n/a
1Y-32.0%
7D-3.4%
1D3.7%
Portfolio Value
​
View

Pharmx Technologies Limited

ASX:PHX Stock Report

Market Cap: AU$56.6m

Pharmx Technologies (PHX) Stock Overview

Engages in the technology and software development business in Australia and New Zealand. More details

PHX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Earnings have declined by 49.7% per year over past 5 years

Does not have a meaningful market cap (A$57M)


PHX Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,653 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
436,653 investors already sharing narratives
View all narratives

Pharmx Technologies Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Pharmx Technologies
Historical stock prices
Current Share PriceAU$0.085
52 Week HighAU$0.20
52 Week LowAU$0.082
Beta0.33
1 Month Change-15.00%
3 Month Change-29.17%
1 Year Change-32.00%
3 Year Change102.38%
5 Year Change6.25%
Change since IPO-99.58%

Recent News & Updates

Analysis Article • Sep 01

Pharmx Technologies (ASX:PHX) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Recent updates

Analysis Article • Sep 01

Pharmx Technologies (ASX:PHX) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article • Feb 12

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

PharmX Technologies Limited ( ASX:PHX ), is not the largest company out there, but it received a lot of attention from...
Analysis Article • Jul 12

A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

Key Insights The projected fair value for Corum Group is AU$0.046 based on 2 Stage Free Cash Flow to Equity Current...
Analysis Article • May 11

At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

Corum Group Limited ( ASX:COO ), might not be a large cap stock, but it saw a significant share price rise of over 20...
Analysis Article • Nov 12

Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • Apr 29

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Corum Group Limited ( ASX:COO ), might not be a large cap stock, but it saw a decent share price growth in the teens...
Analysis Article • Mar 02

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Despite posting strong earnings, Corum Group Limited's ( ASX:COO ) stock didn't move much over the last week. We looked...
Analysis Article • Dec 13

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Corum Group's (ASX:COO) stock is up by a considerable 96% over the past three months. But the company's key financial...

Shareholder Returns

PHXAU SoftwareAU Market
7D-3.4%-7.5%-0.6%
1Y-32.0%-51.4%-0.3%

Return vs Industry: PHX exceeded the Australian Software industry which returned -51.4% over the past year.

Return vs Market: PHX underperformed the Australian Market which returned -0.3% over the past year.

Price Volatility

Is PHX's price volatile compared to industry and market?
PHX volatility
PHX Average Weekly Movement9.2%
Software Industry Average Movement10.6%
Market Average Movement9.7%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.0%

Stable Share Price: PHX has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: PHX's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1950n/aTom Culverpharmx.com.au

Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023.

Pharmx Technologies Limited Fundamentals Summary

How do Pharmx Technologies's earnings and revenue compare to its market cap?
PHX fundamental statistics
Market capAU$56.62m
Earnings (TTM)-AU$1.83m
Revenue (TTM)AU$7.62m
7.4x
P/S Ratio
-31.0x
P/E Ratio

Is PHX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHX income statement (TTM)
RevenueAU$7.62m
Cost of RevenueAU$5.64m
Gross ProfitAU$1.98m
Other ExpensesAU$3.81m
Earnings-AU$1.83m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.0027
Gross Margin25.99%
Net Profit Margin-23.97%
Debt/Equity Ratio0%

How did PHX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 17:43
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharmx Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.